Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Pfalz_AG
|
| gptkbp:awards |
Best Pharmaceutical Company 2022
|
| gptkbp:ceo |
gptkb:John_Doe
|
| gptkbp:certification |
gptkb:standard
|
| gptkbp:employees |
over 500
|
| gptkbp:focus |
research and development
|
| gptkbp:founded |
gptkb:1990
|
| gptkbp:headquarters |
gptkb:government_agency
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pfalz Group
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:location |
gptkb:Mannheim
|
| gptkbp:market |
global
|
| gptkbp:partnerships |
various international pharmaceutical companies
|
| gptkbp:products |
generic drugs
|
| gptkbp:revenue |
approximately $100 million
|
| gptkbp:services |
contract manufacturing
|
| gptkbp:subsidiary |
Pfalz Pharma Gmb H
|
| gptkbp:type |
private
|
| gptkbp:website |
www.pfalzgroup.com
|